Search

Your search keyword '"Chitale D"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Chitale D" Remove constraint Author: "Chitale D"
125 results on '"Chitale D"'

Search Results

51. Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study.

52. The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcinoma.

53. Customizable Natural Language Processing Biomarker Extraction Tool.

54. Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort.

55. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.

56. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.

57. A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusion.

58. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative.

59. Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patients.

60. Atypical Chemokine Receptor 1 ( DARC/ACKR1 ) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.

62. Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men.

63. Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy.

64. Triple-Negative Breast Cancer, Stem Cells, and African Ancestry.

65. Pleomorphic fibroma of the skin with MDM2 immunoreactivity: A potential diagnostic pitfall.

66. Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells.

67. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

68. Investigation into the presence of human papillomavirus in patients with obstructive sleep apnea.

69. Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.

70. Biological significance of genome-wide DNA methylation profiles in keloids.

71. The biological significance of methylome differences in human papilloma virus associated head and neck cancer.

72. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.

73. Mutational Landscape of Aggressive Prostate Tumors in African American Men.

74. Methylation Markers for Early Detection and Differentiation of Follicular Thyroid Cancer Subtypes.

75. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.

76. Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer.

77. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.

78. Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.

79. Array-CGH shows amplification of 8q including MYC as the sole aberration in a leiomyosarcoma of the female lower genital tract.

80. Erratum: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

81. Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.

82. Adenomyoepithelioma of the breast: a brief diagnostic review.

83. Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma.

84. Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.

85. Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

86. Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women.

87. DNA methylation in thyroid tumorigenesis.

88. The role of lymph node metastasis in the systemic dissemination of breast cancer.

89. Genomic and biological characterization of exon 4 KRAS mutations in human cancer.

90. The role of lymph node metastasis in the systemic dissemination of breast cancer.

91. Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods.

92. The Henry Ford production system: LEAN process redesign improves service in the molecular diagnostic laboratory: a paper from the 2008 William Beaumont hospital symposium on molecular pathology.

93. Genetic predictors of MEK dependence in non-small cell lung cancer.

94. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.

95. EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.

96. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.

97. Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.

98. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.

99. Primary cutaneous mucinous carcinoma: presence of myoepithelial cells as a clue to the cutaneous origin.

100. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer.

Catalog

Books, media, physical & digital resources